Genotoxicity Revaluation of Three Commercial Nitroheterocyclic Drugs: Nifurtimox, Benznidazole, and Metronidazole

Nitroheterocyclic compounds are widely used as therapeutic agents against a variety of protozoan and bacterial infections. However, the literature on these compounds, suspected of being carcinogens, is widely controversial. In this study, cytotoxic and genotoxic potential of three drugs, Nifurtimox...

Full description

Saved in:
Bibliographic Details
Main Authors: Annamaria Buschini, Lisa Ferrarini, Susanna Franzoni, Serena Galati, Mirca Lazzaretti, Francesca Mussi, Cristina Northfleet de Albuquerque, Tânia Maria Araújo Domingues Zucchi, Paola Poli
Format: Article
Language:English
Published: Wiley 2009-01-01
Series:Journal of Parasitology Research
Online Access:http://dx.doi.org/10.1155/2009/463575
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549571674243072
author Annamaria Buschini
Lisa Ferrarini
Susanna Franzoni
Serena Galati
Mirca Lazzaretti
Francesca Mussi
Cristina Northfleet de Albuquerque
Tânia Maria Araújo Domingues Zucchi
Paola Poli
author_facet Annamaria Buschini
Lisa Ferrarini
Susanna Franzoni
Serena Galati
Mirca Lazzaretti
Francesca Mussi
Cristina Northfleet de Albuquerque
Tânia Maria Araújo Domingues Zucchi
Paola Poli
author_sort Annamaria Buschini
collection DOAJ
description Nitroheterocyclic compounds are widely used as therapeutic agents against a variety of protozoan and bacterial infections. However, the literature on these compounds, suspected of being carcinogens, is widely controversial. In this study, cytotoxic and genotoxic potential of three drugs, Nifurtimox (NFX), Benznidazole (BNZ), and Metronidazole (MTZ) was re-evaluated by different assays. Only NFX reduces survival rate in actively proliferating cells. The compounds are more active for base-pair substitution than frameshift induction in Salmonella; NFX and BNZ are more mutagenic than MTZ; they are widely dependent from nitroreduction whereas microsomal fraction S9 weakly affects the mutagenic potential. Comet assay detects BNZ- and NFX-induced DNA damage at doses in the range of therapeutically treated patient plasma concentration; BNZ seems to mainly act through ROS generation whereas a dose-dependent mechanism of DNA damaging is suggested for NFX. The lack of effects on mammalian cells for MTZ is confirmed also in MN assay whereas MN induction is observed for NFX and BNZ. The effects of MTZ, that shows comparatively low reduction potential, seem to be strictly dependent on anaerobic/hypoxic conditions. Both NFX and BNZ may not only lead to cellular damage of the infective agent but also interact with the DNA of mammalian cells.
format Article
id doaj-art-402fb07236374fe98421e96be2cc5d9e
institution Kabale University
issn 2090-0023
2090-0031
language English
publishDate 2009-01-01
publisher Wiley
record_format Article
series Journal of Parasitology Research
spelling doaj-art-402fb07236374fe98421e96be2cc5d9e2025-02-03T06:10:52ZengWileyJournal of Parasitology Research2090-00232090-00312009-01-01200910.1155/2009/463575463575Genotoxicity Revaluation of Three Commercial Nitroheterocyclic Drugs: Nifurtimox, Benznidazole, and MetronidazoleAnnamaria Buschini0Lisa Ferrarini1Susanna Franzoni2Serena Galati3Mirca Lazzaretti4Francesca Mussi5Cristina Northfleet de Albuquerque6Tânia Maria Araújo Domingues Zucchi7Paola Poli8Dipartimento di Genetica, Biologia dei Microrganismi, Antropologia, Evoluzione, Università di Parma, Parco Area delle Scienze, 11/a, 43100 Parma, ItalyDipartimento di Genetica, Biologia dei Microrganismi, Antropologia, Evoluzione, Università di Parma, Parco Area delle Scienze, 11/a, 43100 Parma, ItalyDipartimento di Genetica, Biologia dei Microrganismi, Antropologia, Evoluzione, Università di Parma, Parco Area delle Scienze, 11/a, 43100 Parma, ItalyDipartimento di Genetica, Biologia dei Microrganismi, Antropologia, Evoluzione, Università di Parma, Parco Area delle Scienze, 11/a, 43100 Parma, ItalyDipartimento di Genetica, Biologia dei Microrganismi, Antropologia, Evoluzione, Università di Parma, Parco Area delle Scienze, 11/a, 43100 Parma, ItalyDipartimento di Genetica, Biologia dei Microrganismi, Antropologia, Evoluzione, Università di Parma, Parco Area delle Scienze, 11/a, 43100 Parma, ItalyDepartamento de Tecnologia Bioquímico Farmacêutica, Faculdade de Ciências Farmacêuticas, USP, Avenida Prof. Lineu Prestes, 580, Cidade Universitária, 05508-900 São Paulo, BrazilDepartamento de Parasitologia, Instituto de Ciências Biomédicas, USP, Avenida Prof. Lineu Prestes, 1374, Cidade Universitária, 05508-900 São Paulo, BrazilDipartimento di Genetica, Biologia dei Microrganismi, Antropologia, Evoluzione, Università di Parma, Parco Area delle Scienze, 11/a, 43100 Parma, ItalyNitroheterocyclic compounds are widely used as therapeutic agents against a variety of protozoan and bacterial infections. However, the literature on these compounds, suspected of being carcinogens, is widely controversial. In this study, cytotoxic and genotoxic potential of three drugs, Nifurtimox (NFX), Benznidazole (BNZ), and Metronidazole (MTZ) was re-evaluated by different assays. Only NFX reduces survival rate in actively proliferating cells. The compounds are more active for base-pair substitution than frameshift induction in Salmonella; NFX and BNZ are more mutagenic than MTZ; they are widely dependent from nitroreduction whereas microsomal fraction S9 weakly affects the mutagenic potential. Comet assay detects BNZ- and NFX-induced DNA damage at doses in the range of therapeutically treated patient plasma concentration; BNZ seems to mainly act through ROS generation whereas a dose-dependent mechanism of DNA damaging is suggested for NFX. The lack of effects on mammalian cells for MTZ is confirmed also in MN assay whereas MN induction is observed for NFX and BNZ. The effects of MTZ, that shows comparatively low reduction potential, seem to be strictly dependent on anaerobic/hypoxic conditions. Both NFX and BNZ may not only lead to cellular damage of the infective agent but also interact with the DNA of mammalian cells.http://dx.doi.org/10.1155/2009/463575
spellingShingle Annamaria Buschini
Lisa Ferrarini
Susanna Franzoni
Serena Galati
Mirca Lazzaretti
Francesca Mussi
Cristina Northfleet de Albuquerque
Tânia Maria Araújo Domingues Zucchi
Paola Poli
Genotoxicity Revaluation of Three Commercial Nitroheterocyclic Drugs: Nifurtimox, Benznidazole, and Metronidazole
Journal of Parasitology Research
title Genotoxicity Revaluation of Three Commercial Nitroheterocyclic Drugs: Nifurtimox, Benznidazole, and Metronidazole
title_full Genotoxicity Revaluation of Three Commercial Nitroheterocyclic Drugs: Nifurtimox, Benznidazole, and Metronidazole
title_fullStr Genotoxicity Revaluation of Three Commercial Nitroheterocyclic Drugs: Nifurtimox, Benznidazole, and Metronidazole
title_full_unstemmed Genotoxicity Revaluation of Three Commercial Nitroheterocyclic Drugs: Nifurtimox, Benznidazole, and Metronidazole
title_short Genotoxicity Revaluation of Three Commercial Nitroheterocyclic Drugs: Nifurtimox, Benznidazole, and Metronidazole
title_sort genotoxicity revaluation of three commercial nitroheterocyclic drugs nifurtimox benznidazole and metronidazole
url http://dx.doi.org/10.1155/2009/463575
work_keys_str_mv AT annamariabuschini genotoxicityrevaluationofthreecommercialnitroheterocyclicdrugsnifurtimoxbenznidazoleandmetronidazole
AT lisaferrarini genotoxicityrevaluationofthreecommercialnitroheterocyclicdrugsnifurtimoxbenznidazoleandmetronidazole
AT susannafranzoni genotoxicityrevaluationofthreecommercialnitroheterocyclicdrugsnifurtimoxbenznidazoleandmetronidazole
AT serenagalati genotoxicityrevaluationofthreecommercialnitroheterocyclicdrugsnifurtimoxbenznidazoleandmetronidazole
AT mircalazzaretti genotoxicityrevaluationofthreecommercialnitroheterocyclicdrugsnifurtimoxbenznidazoleandmetronidazole
AT francescamussi genotoxicityrevaluationofthreecommercialnitroheterocyclicdrugsnifurtimoxbenznidazoleandmetronidazole
AT cristinanorthfleetdealbuquerque genotoxicityrevaluationofthreecommercialnitroheterocyclicdrugsnifurtimoxbenznidazoleandmetronidazole
AT taniamariaaraujodomingueszucchi genotoxicityrevaluationofthreecommercialnitroheterocyclicdrugsnifurtimoxbenznidazoleandmetronidazole
AT paolapoli genotoxicityrevaluationofthreecommercialnitroheterocyclicdrugsnifurtimoxbenznidazoleandmetronidazole